Back to Journals » Cancer Management and Research » Internal Scope Notes

Cancer Management and Research

ISSN: 1179-1322

Internal Scope Notes

> NO Tissue microarray or SNP studies
> Cancer predisposition syndromes are okay but benign tumors such as some gliomas that are not cancerous are out of scope
> Cell lines must be rigorous
> Biomarkers require in vivo validation experiments
> Bibliometric okay if accompanied by a meta-analysis (although meta analyses on its own are currently not in scope)